LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 186 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,012,000 | +11.0% | 7,433 | -1.1% | 0.26% | +5.8% |
| Q2 2017 | $912,000 | +10.1% | 7,512 | -4.0% | 0.24% | +9.5% |
| Q1 2017 | $828,000 | +1.8% | 7,825 | -2.2% | 0.22% | -3.5% |
| Q4 2016 | $813,000 | -6.4% | 8,002 | -6.1% | 0.23% | -6.9% |
| Q3 2016 | $869,000 | -17.9% | 8,518 | -4.0% | 0.24% | -20.2% |
| Q2 2016 | $1,058,000 | +80.9% | 8,874 | -5.4% | 0.31% | +95.5% |
| Q2 2014 | $585,000 | -4.9% | 9,384 | +2.6% | 0.16% | -8.7% |
| Q1 2014 | $615,000 | – | 9,146 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |